APA (7th ed.) Citation

Mujalli, A., Farrash, W. F., Obaid, A. A., Khan, A. A., Almaimani, R. A., Idris, S., . . . Refaat, B. (2023). Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 24(24), 17380. https://doi.org/10.3390/ijms242417380

Chicago Style (17th ed.) Citation

Mujalli, Abdulrahman, et al. "Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus." International Journal of Molecular Sciences 24, no. 24 (2023): 17380. https://doi.org/10.3390/ijms242417380.

MLA (9th ed.) Citation

Mujalli, Abdulrahman, et al. "Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus." International Journal of Molecular Sciences, vol. 24, no. 24, 2023, p. 17380, https://doi.org/10.3390/ijms242417380.